A study in humans identified the mir-8055 as a biomarker for recurrent myocardial infarction risk, where it was downregulated in whole blood of patients with recurrent MI after percutaneous coronary intervention compared to those without, remaining significant after false discovery rate correction (FDR <0.1) in the replication cohort, though it was not significantly different in plasma samples [Onuoha et al. DOI:10.1111/cts.13307].